A retrospective case–control pharmacogenetic study of ALT elevation in lapatinib-treated breast cancer patients revealed a strong genetic association between elevated ALT and the HLA alleles DQA1*02:01 and DRB1*07:01, suggesting a possibility of immune-mediated pathogenesis [4,5]. Here, GPT is linked to breast cancer.